Angusta 25 Mikrogramm Tabletten

Recall | Medicines | 27/06/2022

The marketing authorisation holder informed its customers on June 24, 2022, that due to contamination the mentioned medicinal product is recalled as a precautionary measure. The risk of the contamination has been determined to be low.

Name of the medicinal product Angusta 25 Mikrogramm Tabletten
Marketing authorisation number(s) 140316
CIP code 4984654
Marketing authorisation holder Norgine B.V.
Batch number(s) Batch, Expiry Date
B27754, 30.09.2023
B28186, 31.08.2024
Classification of the recall2
Depth of recall Pharmacies

Further inquiry note